Bio-IT World | In the not-so-distant future, the pharmaceutical industry will need to move away from serendipity and its “blockbuster” drug development approach to become a service-based business specializing in patient-specific therapeutics delivering desired outcomes at the desired price. Clinical trials, of necessity, will be re-engineered to reflect real-world circumstances and turn adaptive study programs into a competitive advantage. Practicing clinicians will be dissuaded from using high-cost medicines and more actively participate in modeling and simulation exercises to help get better products to patients sooner.
|
|
|
January 17th, 2012 BIO ITWORLD.COM ARCHIVES CHI CONFERENCES ADVERTISING RSS
|
January 10th, 2012 BIO ITWORLD.COM ARCHIVES CHI CONFERENCES ADVERTISING RSS
|
January 3rd, 2012 BIO ITWORLD.COM ARCHIVES CHI CONFERENCES ADVERTISING RSS
|
December 20th, 2011 BIO ITWORLD.COM ARCHIVES CHI CONFERENCES ADVERTISING RSS LOGIN REGISTER
|
December 13th, 2011 BIO ITWORLD.COM ARCHIVES CHI CONFERENCES ADVERTISING RSS
|
December 6th, 2011 BIO ITWORLD.COM ARCHIVES CHI CONFERENCES ADVERTISING RSS
|
November 29th, 2011 BIO ITWORLD.COM ARCHIVES CHI CONFERENCES ADVERTISING RSS
|
November 22nd, 2011 BIO ITWORLD.COM ARCHIVES CHI CONFERENCES ADVERTISING RSS
|
November 15th, 2011 BIO ITWORLD.COM ARCHIVES CHI CONFERENCES ADVERTISING RSS
|
|
|
Researchers identify four cognitive biases that might be slowing drug discovery. By Courtney Andersen March 29, 2011 | In an age of increasing financial and logistical pressures facing biotech and pharmaceutical companies, optimizing R&D success is a critical task. But
|
New simulation tool expands the range of eligible trials. By Deb Borfitz November 16, 2010 | The first upgrade to a one of a kind simulation tool co developed by Tessella and Berry Consultants significantly enlarges the proportion of clinical
|
New simulation tool expands the range of eligible trials. By Deb Borfitz November 16, 2010 | The first upgrade to a one of a kind simulation tool co developed by Tessella and Berry Consultants significantly enlarges the proportion of clinical
|
Bio-IT World | The first upgrade to the FACTS simulation tool, co-developed by Tessella and Berry Consultants, increases the proportion of clinical studies that can benefit from simulation of the design up to about 85%.
|
Bio-IT World | Last April, we handed out the Bio•IT World 2010 Best Practices Awards at a lavish awards ceremony in Boston during the Bio-IT World Conference & Expo. Here you’ll find profiles of the six category winners and three other awards: the Editors’ Choice Award, the Judges’ Prize, and a Community Service Award.
|
By Kevin Davies July 26, 2010 | First Base | One of the undoubted highlights of our professional calendar is the second night of our annual Bio IT World Conference & Expo, when we host a gala dinner for the
|
July 26, 2010 | Last April, we handed out the Bio•IT World 2010 Best Practices Awards at a lavish awards ceremony in Boston during the Bio IT World Conference & Expo. Last October groups were invited to submit outstanding and
|
Bio-IT World | BOSTON—Bio-IT World has just announced the winners of its sixth Best Practices Awards program. Grand Prize winners from six life sciences awards categories were Bristol-Myers Squibb, The Scripps Research Institute, PROOF / iCAPTURE Centre of Excellence, Massachusetts Institute of Technology, Centocor R&D, and FDA. The competition’s second Judges’ Prize was awarded to goBalto.com; the Editors’ Choice Award was awarded to Merck and Co. and the competition’s first Community Service Prize recognizing excellence in open source was awarded to the Royal Society of Chemistry.
|